Obermatt
See Similar Stocks →

Stratec

GER:SBS · DE000STRA555
Health Care Equipment & SuppliesSmall

360

36
EV / EBIT44
Price / Owner Earnings1
Owner Earnings Yield65
Dividend Yield87
Price/Sales78
EV / Gross Profit38
Price/Book77
Return on Capital67
Cash Return on Capital65
Return on Equity61
EBIT Margin65
Gross Profitability10
Accruals52
Owner Earnings Margin65
Sales growth47
Profit Growth34
Long-Term EPS Growth88
Owner Earnings Growth16
Reinvestment66
Price momentum17
Debt load46
Refinancing94
Debt Payback6
Liquidity71
Analyst ratings33
Opinion Changes50
Price Target Upside30
Market mood51
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Stratec doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryGermany
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeXTRA
Founded2018
Employees284
Websitestratec.com
ISINDE000STRA555
Last UpdateApr 2, 2026
Indices
CDAX (Germany)
Themes
Health DiagnosticsIndustrial AutomationSensorsBiomedical EngineeringDetectors, Sensors and MemsBiotechnologyHealth CareManufacturingPharmaceutical

Description

STRATEC SE operates designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences. Business Segments The company operates primarily in the realm of medical technology through multiple busi…

Analysis

Middle-of-the-road

Stratec SE sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 5033.6×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
77
2023202420252026

All-time high

89

Mar 2026

All-time low

33

Sep 2025

Average rank

58

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
78
81
73
58
Price/Earnings
59
75
75
49
Price/Book
77
87
77
44
Dividend Yield
87
90
72
67
Value (overall)
96
96
91
84

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Stratec with its peers
Anbio Biotechnology
NMQ:NNNN
—
CountryGermany
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
SCHMID Group
NMQ:SHMD
15
CountryGermany
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Raspberry Pi
LSE:RPI
54
CountryUK
IndustryTechnology Hardware, Storage & Peripherals
SizeSmall
Full Stock Analysis →
Big Technologies
LSE:BIG
25
CountryUK
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Sealsq
NSQ:LAES
4
CountrySwitzerland
IndustrySemiconductors & Semiconductor Equipment
SizeSmall
Full Stock Analysis →
Molten Ventures
LSE:GROW
98
CountryUK
IndustryCapital Markets
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →